From Wikipedia, the free encyclopedia
|Chemical and physical data|
|Molar mass||146.25 kg/mol|
|(what is this?)|
Sifalimumab was developed by MedImmune.
- "Statement On A Nonproprietary Name Adopted By The USAN Council: Sifalimumab" (PDF). American Medical Association.
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|